血浆游离DNA片段化模式与前列腺癌生化复发患者PSMA PET/CT体积参数所测肿瘤负荷相关
这项前瞻性研究分析了32例前列腺癌生化复发患者的PSMA PET/CT与液体活检结果,评估cfDNA与分子影像肿瘤负荷的相关性。结果显示cfDNA平均片段大小分数与全身PSMA-TV呈负相关(Spearman相关系数-0.451,P=0.009),而cfDNA浓度与PET-PSMA数据无相关性。作者认为液体活检有望作为生物标志物及PSMA PET/CT的补充工具用于随访中评估疾病进展。
要点
- 32例生化复发患者中12例(37.5%)PSMA PET未见可测量病灶。
- PSA水平与全身PSMA-TV、PSMA-TL、SUVmean及SUVmax相关(P<0.05)。
- cfDNA平均片段大小分数与全身PSMA-TV呈负相关(ρ=-0.451,P=0.009)。
核心结论
- 这项前瞻性研究显示,在推测为局限期前列腺癌且早期生化复发的患者中,cfDNA片段化模式与PSMA PET/CT体积参数呈统计学显著负相关。
- 作者认为这些发现凸显了液体活检作为生物标志物及PSMA PET/CT补充工具、用于此类患者随访中评估疾病进展的潜力。
研究设计与样本
- 前瞻性研究,分析32例生化复发前列腺癌患者的PSMA PET/CT与液体活检结果。
主要发现
- 12例患者(37.5%)无PSMA PET可测量疾病。
- 4例(12.5%)为局部复发,7例(21.9%)为盆腔淋巴结复发(其中1例同时有局部复发),9例(28.1%)为转移性复发(伴或不伴局部或淋巴结复发)。
- PSA水平与分子影像数据相关(p < 0.05),包括全身PSMA-TV、全身PSMA-TL、全身SUVmean和全身SUVmax。
- cfDNA平均片段大小分数与全身PSMA-TV所测肿瘤负荷呈负相关,Spearman相关系数为-0.451,p值为0.009。
- cfDNA浓度与PET-PSMA数据之间未发现相关性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prostate cancer recurrence following primary treatment poses a significant clinical challenge, particularly when detected through biochemical recurrence at low PSA levels. Conventional imaging modalities often fail to localize the disease at this early stage. PSMA PET has demonstrated superior sensitivity in detecting recurrent lesions, even in patients with low PSA. Concurrently, liquid biopsy, through analysis of cell-free DNA (cfDNA), offers a minimally invasive approach for monitoring disease. There is scarce evidence about the association between liquid biopsy and PSMA PET/CT findings. This study aimed to assess the correlation between liquid biopsy and tumor burden assessed by PSMA PET/CT in early recurring prostate cancer patients. RESULTS: PSMA PET/CT and liquid biopsies of 32 patients in biochemical recurrence were analyzed. 12 patients (37.5%) had no PSMA PET-measurable disease. Four patients (12.5%) presented local recurrence, seven (21.9%) had recurrence in pelvic lymph nodes, one of whom also had local recurrence. Nine patients (28.1%) presented metastatic recurrence, with or without local or nodal recurrence. PSA levels correlated with molecular imaging data (p < 0.05), including whole body PSMA-TV, whole body PSMA-TL, whole body SUVmean and whole body SUVmax. The mean cfDNA fragment size fraction was inversely correlated with tumour burden measured with whole body PSMA-TV, with a Spearman correlation coefficient of -0.451 and a p-value of 0.009. No correlation was found between cfDNA concentration and PET-PSMA data. CONCLUSION: This prospective study demonstrated a statistically significant negative correlation between cfDNA fragmentation patterns and PSMA PET/CT volumetric parameters in patients with presumed localized prostate cancer with early biochemical recurrence. These findings underscore the potential of liquid biopsy as a biomarker and a complementary tool to PSMA PET/CT to assess disease progression during the follow-up of these patients.
引用
- Amseian G, Figueras M, Mases J, et al. cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancer. EJNMMI Res. 2024. PMID: 39694939. doi:10.1186/s13550-024-01170-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。